Doogan Declaninsider trades

In SEC Form 4 filings, Doogan Declan is listed as Director of Tenax Therapeutics, Inc. (TENX). In the last 90 days, Doogan Declan bought $101.8K of Tenax Therapeutics, Inc. (TENX) on the open market and sold none. The purchase was $101.8K of Tenax Therapeutics, Inc. (TENX) on Sep 16. Took part in a cluster buy; the latest at Tenax Therapeutics, Inc. (TENX), where 4 insiders bought within 14 days, ending Sep 16.

Companies and roles

Company	Role	Transactions	Last filed
TENXTenax Therapeutics, Inc.	Director	1	Sep 17

Cluster buys

TENX: 4 insiders bought $1.74M between Sep 3 – Sep 16.

Form 4 historysince 2026-09-17

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
TENXTenax Therapeutics, Inc.	Sep 16	Sep 17	P	53,000	$1.92	Purchase +$101,760	55,274	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.